AstraZeneca is seeking FDA approval to market Seroquel XR for treating depression and anxiety.
阿斯利康正在征求FDA批准奎硫平缓释片用于治疗抑郁症和焦虑症。
Seroquel use was associated with a nearly threefold adjusted increase in risk among the study population.
使用思瑞康与研究人群中校正风险增加接近3倍有关。
Seroquel XR is an extended release version of the medicine with a longer patent life than the original formulation.
奎硫平缓释片是该药的一个延长释放的版本。 它比奎硫平有更长的专利寿命。
应用推荐